Insider transactions

EDGAR

Aclaris Therapeutics, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-20.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
1 transactions, 300,000 shares
Sum of shares × price per share: 1,359,000

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 87

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-08-01 Filed 2026-08-04Kolbeck Roland Wilhelm Officer: Chief Scientific Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)36,375——36,375Direct (D) No
F1
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
Open filing 0002076327-26-000006 Read from the filing’s XML Dispute this row
2026-08-01 Filed 2026-08-04Kolbeck Roland Wilhelm Officer: Chief Scientific Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)12,3855.20
64,402

Derived: shares × price per share. Exact value 64402.00.

23,990Direct (D) No
F2
  • F2 The transaction reported represents the withholding of shares by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units described in this Form 4.
Open filing 0002076327-26-000006 Read from the filing’s XML Dispute this row
2026-08-01 Filed 2026-08-04Kolbeck Roland Wilhelm Officer: Chief Scientific Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (36,375)
Disposed (D)36,3750—109,125Direct (D) No
F1, F3
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
  • F3 The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of August 1, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
Open filing 0002076327-26-000006 Read from the filing’s XML Dispute this row
2026-06-05 Filed 2026-06-08Humphries William D. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)11,580——45,105Direct (D) No
F1
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
Open filing 0001674278-26-000002 Read from the filing’s XML Dispute this row
2026-06-05 Filed 2026-06-08Humphries William D. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (11,580)
Disposed (D)11,5800—0Direct (D) No
F1, F5
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
  • F5 The shares underlying these restricted stock units vested on June 5, 2026.
Open filing 0001674278-26-000002 Read from the filing’s XML Dispute this row
2026-06-05 Filed 2026-06-08Mehra Anand Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)11,580——726,403Direct (D) No
F1
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
Open filing 0001590102-26-000002 Read from the filing’s XML Dispute this row
2026-06-05 Filed 2026-06-08Mehra Anand Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (11,580)
Disposed (D)11,5800—0Direct (D) No
F1, F5
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
  • F5 The shares underlying these restricted stock units vested on June 5, 2026.
Open filing 0001590102-26-000002 Read from the filing’s XML Dispute this row
2026-06-05 Filed 2026-06-08Molineaux Christopher P. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)11,580——69,536Direct (D) No
F1
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
Open filing 0001654773-26-000003 Read from the filing’s XML Dispute this row
2026-06-05 Filed 2026-06-08Molineaux Christopher P. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (11,580)
Disposed (D)11,5800—0Direct (D) No
F1, F5
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
  • F5 The shares underlying these restricted stock units vested on June 5, 2026.
Open filing 0001654773-26-000003 Read from the filing’s XML Dispute this row
2026-06-05 Filed 2026-06-08GOWEN MAXINE Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)11,580——33,334Direct (D) No
F1
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
Open filing 0001280044-26-000004 Read from the filing’s XML Dispute this row
2026-06-05 Filed 2026-06-08GOWEN MAXINE Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (11,580)
Disposed (D)11,5800—0Direct (D) No
F1, F5
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
  • F5 The shares underlying these restricted stock units vested on June 5, 2026.
Open filing 0001280044-26-000004 Read from the filing’s XML Dispute this row
2026-06-05 Filed 2026-06-08SCHIFF ANDREW N Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)11,580——25,540Direct (D) No
F1
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
Open filing 0001172252-26-000002 Read from the filing’s XML Dispute this row
2026-06-05 Filed 2026-06-08SCHIFF ANDREW N Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (11,580)
Disposed (D)11,5800—0Direct (D) No
F1, F6
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
  • F6 The shares underlying these restricted stock units vested on June 5, 2026.
Open filing 0001172252-26-000002 Read from the filing’s XML Dispute this row
2026-06-05 Filed 2026-06-08MILANO VINCENT Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)11,580——28,896Direct (D) No
F1
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
Open filing 0001187159-26-000002 Read from the filing’s XML Dispute this row
2026-06-05 Filed 2026-06-08MILANO VINCENT Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (11,580)
Disposed (D)11,5800—0Direct (D) No
F1, F5
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
  • F5 The shares underlying these restricted stock units vested on June 5, 2026.
Open filing 0001187159-26-000002 Read from the filing’s XML Dispute this row
2026-06-04 Filed 2026-06-08Humphries William D. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (42,350) — exercise price 4.71
Acquired (A)42,3500—42,350Direct (D) No
F2, F3
  • F2 The shares subject to this stock option will vest in twelve equal monthly installments commencing on July 4, 2026, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2025 Equity Incentive Plan, or the Plan) through each such vesting date.
  • F3 This grant was made pursuant to the issuer's tenth amended and restated non-employee director compensation policy.
Open filing 0001674278-26-000002 Read from the filing’s XML Dispute this row
2026-06-04 Filed 2026-06-08Humphries William D. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (10,987)
Acquired (A)10,9870—10,987Direct (D) No
F1, F4, F3
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
  • F4 The shares underlying these restricted stock units will vest in one installment on June 4, 2027, subject to the Reporting Person's Continuous Service (as defined in the Plan) as of such date.
  • F3 This grant was made pursuant to the issuer's tenth amended and restated non-employee director compensation policy.
Open filing 0001674278-26-000002 Read from the filing’s XML Dispute this row
2026-06-04 Filed 2026-06-08Mehra Anand Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (42,350) — exercise price 4.71
Acquired (A)42,3500—42,350Direct (D) No
F2, F3
  • F2 The shares subject to this stock option will vest in twelve equal monthly installments commencing on July 4, 2026, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2025 Equity Incentive Plan, or the Plan) through each such vesting date.
  • F3 This grant was made pursuant to the issuer's tenth amended and restated non-employee director compensation policy.
Open filing 0001590102-26-000002 Read from the filing’s XML Dispute this row
2026-06-04 Filed 2026-06-08Mehra Anand Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (10,987)
Acquired (A)10,9870—10,987Direct (D) No
F1, F4, F3
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
  • F4 The shares underlying these restricted stock units will vest in one installment on June 4, 2027, subject to the Reporting Person's Continuous Service (as defined in the Plan) as of such date.
  • F3 This grant was made pursuant to the issuer's tenth amended and restated non-employee director compensation policy.
Open filing 0001590102-26-000002 Read from the filing’s XML Dispute this row
2026-06-04 Filed 2026-06-08Molineaux Christopher P. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (42,350) — exercise price 4.71
Acquired (A)42,3500—42,350Direct (D) No
F2, F3
  • F2 The shares subject to this stock option will vest in twelve equal monthly installments commencing on July 4, 2026, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2025 Equity Incentive Plan, or the Plan) through each such vesting date.
  • F3 This grant was made pursuant to the issuer's tenth amended and restated non-employee director compensation policy.
Open filing 0001654773-26-000003 Read from the filing’s XML Dispute this row
2026-06-04 Filed 2026-06-08Molineaux Christopher P. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (10,987)
Acquired (A)10,9870—10,987Direct (D) No
F1, F4, F3
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
  • F4 The shares underlying these restricted stock units will vest in one installment on June 4, 2027, subject to the Reporting Person's Continuous Service (as defined in the Plan) as of such date.
  • F3 This grant was made pursuant to the issuer's tenth amended and restated non-employee director compensation policy.
Open filing 0001654773-26-000003 Read from the filing’s XML Dispute this row
2026-06-04 Filed 2026-06-08GOWEN MAXINE Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (42,350) — exercise price 4.71
Acquired (A)42,3500—42,350Direct (D) No
F2, F3
  • F2 The shares subject to this stock option will vest in twelve equal monthly installments commencing on July 4, 2026, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2025 Equity Incentive Plan, or the Plan) through each such vesting date.
  • F3 This grant was made pursuant to the issuer's tenth amended and restated non-employee director compensation policy.
Open filing 0001280044-26-000004 Read from the filing’s XML Dispute this row
2026-06-04 Filed 2026-06-08GOWEN MAXINE Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (10,987)
Acquired (A)10,9870—10,987Direct (D) No
F1, F4, F3
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
  • F4 The shares underlying these restricted stock units will vest in one installment on June 4, 2027, subject to the Reporting Person's Continuous Service (as defined in the Plan) as of such date.
  • F3 This grant was made pursuant to the issuer's tenth amended and restated non-employee director compensation policy.
Open filing 0001280044-26-000004 Read from the filing’s XML Dispute this row
2026-06-04 Filed 2026-06-08SCHIFF ANDREW N Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (42,350) — exercise price 4.71
Acquired (A)42,3500—42,350Direct (D) No
F3, F4
  • F3 The shares subject to this stock option will vest in twelve equal monthly installments commencing on July 4, 2026, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2025 Equity Incentive Plan, or the Plan) through each such vesting date.
  • F4 This grant was made pursuant to the issuer's tenth amended and restated non-employee director compensation policy.
Open filing 0001172252-26-000002 Read from the filing’s XML Dispute this row
2026-06-04 Filed 2026-06-08SCHIFF ANDREW N Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (10,987)
Acquired (A)10,9870—10,987Direct (D) No
F1, F5, F4
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
  • F5 The shares underlying these restricted stock units will vest in one installment on June 4, 2027, subject to the Reporting Person's Continuous Service (as defined in the Plan) as of such date.
  • F4 This grant was made pursuant to the issuer's tenth amended and restated non-employee director compensation policy.
Open filing 0001172252-26-000002 Read from the filing’s XML Dispute this row
2026-06-04 Filed 2026-06-08MILANO VINCENT Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (42,350) — exercise price 4.71
Acquired (A)42,3500—42,350Direct (D) No
F2, F3
  • F2 The shares subject to this stock option will vest in twelve equal monthly installments commencing on July 4, 2026, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2025 Equity Incentive Plan, or the Plan) through each such vesting date.
  • F3 This grant was made pursuant to the issuer's tenth amended and restated non-employee director compensation policy.
Open filing 0001187159-26-000002 Read from the filing’s XML Dispute this row
2026-06-04 Filed 2026-06-08MILANO VINCENT Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (10,987)
Acquired (A)10,9870—10,987Direct (D) No
F1, F4, F3
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
  • F4 The shares underlying these restricted stock units will vest in one installment on June 4, 2027, subject to the Reporting Person's Continuous Service (as defined in the Plan) as of such date.
  • F3 This grant was made pursuant to the issuer's tenth amended and restated non-employee director compensation policy.
Open filing 0001187159-26-000002 Read from the filing’s XML Dispute this row
2026-05-01 Filed 2026-05-05Hall Jesse Wayne Officer: Chief Medical Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)36,375——36,375Direct (D) No
F1
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
Open filing 0002065269-26-000004 Read from the filing’s XML Dispute this row
2026-05-01 Filed 2026-05-05Hall Jesse Wayne Officer: Chief Medical Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)9,3304.41
41,145.3

Derived: shares × price per share. Exact value 41145.30.

27,045Direct (D) No
F2
  • F2 The transaction reported represents the withholding of shares by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units described in this Form 4.
Open filing 0002065269-26-000004 Read from the filing’s XML Dispute this row
2026-05-01 Filed 2026-05-05Hall Jesse Wayne Officer: Chief Medical Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (36,375)
Disposed (D)36,3750—109,125Direct (D) No
F1, F3
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
  • F3 The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of May 1, 2025, subject to the Continuous Service (as defined in the Issuer's 2024 Inducement Plan) of the Reporting Person as of each such date.
Open filing 0002065269-26-000004 Read from the filing’s XML Dispute this row
2026-04-23 Filed 2026-04-27Leonard Braden Michael 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)300,0004.53
1,359,000

Derived: shares × price per share. Exact value 1359000.00.

13,950,000Indirect (I) Holdings of BML Investment Partners, L.P.No
F1
  • F1 BML Capital Management, LLC (BML Capital) serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the Fund), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
Open filing 0001373604-26-000034 Read from the filing’s XML Dispute this row
2026-03-01 Filed 2026-03-03Balthaser Kevin Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)2,375——188,130Direct (D) No
F1
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
Open filing 0001957554-26-000011 Read from the filing’s XML Dispute this row
2026-03-01 Filed 2026-03-03Balthaser Kevin Officer: Chief Financial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)6772.87
1,942.99

Derived: shares × price per share. Exact value 1942.99.

187,453Direct (D) No
F2
  • F2 The transaction reported represents the withholding of shares by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units described in this Form 4.
Open filing 0001957554-26-000011 Read from the filing’s XML Dispute this row
2026-03-01 Filed 2026-03-03Balthaser Kevin Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (2,375)
Disposed (D)2,3750—0Direct (D) No
F1, F3
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
  • F3 The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2023, subject to the Continuous Service of the Reporting Person (as defined in the Plan) as of the applicable vesting date.
Open filing 0001957554-26-000011 Read from the filing’s XML Dispute this row
2026-02-03 Filed 2026-02-05Balthaser Kevin Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)22,025——192,204Direct (D) No
F1
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
Open filing 0001957554-26-000007 Read from the filing’s XML Dispute this row
2026-02-03 Filed 2026-02-05Balthaser Kevin Officer: Chief Financial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)6,4493.47
22,378.03

Derived: shares × price per share. Exact value 22378.03.

185,755Direct (D) No
F2
  • F2 The transaction reported represents the withholding of shares by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units described in this Form 4.
Open filing 0001957554-26-000007 Read from the filing’s XML Dispute this row
2026-02-03 Filed 2026-02-05Balthaser Kevin Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (22,025)
Disposed (D)22,0250—66,075Direct (D) No
F1, F3
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
  • F3 The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 3, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
Open filing 0001957554-26-000007 Read from the filing’s XML Dispute this row
2026-02-03 Filed 2026-02-05Walker Neal Director · Officer: CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)63,475——1,562,497Direct (D) No
F1
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
Open filing 0001604457-26-000005 Read from the filing’s XML Dispute this row
2026-02-03 Filed 2026-02-05Walker Neal Director · Officer: CEO
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)18,6113.47
64,580.17

Derived: shares × price per share. Exact value 64580.17.

1,543,886Direct (D) No
F2
  • F2 The transaction reported represents the withholding of shares by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units described in this Form 4.
Open filing 0001604457-26-000005 Read from the filing’s XML Dispute this row
2026-02-03 Filed 2026-02-05Walker Neal Director · Officer: CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (63,475)
Disposed (D)63,4750—190,425Direct (D) No
F1, F3
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
  • F3 The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 3, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
Open filing 0001604457-26-000005 Read from the filing’s XML Dispute this row
2026-02-03 Filed 2026-02-05Loerop James Officer: Chief Business Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)20,875——198,197Direct (D) No
F1
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
Open filing 0001781549-26-000011 Read from the filing’s XML Dispute this row
2026-02-03 Filed 2026-02-05Loerop James Officer: Chief Business Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)5,9373.47
20,601.39

Derived: shares × price per share. Exact value 20601.39.

192,260Direct (D) No
F2
  • F2 The transaction reported represents the withholding of shares by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units described in this Form 4.
Open filing 0001781549-26-000011 Read from the filing’s XML Dispute this row
2026-02-03 Filed 2026-02-05Loerop James Officer: Chief Business Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (20,875)
Disposed (D)20,8750—62,625Direct (D) No
F1, F3
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
  • F3 The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 3, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
Open filing 0001781549-26-000011 Read from the filing’s XML Dispute this row
2026-02-03 Filed 2026-02-05Davis Hugh M. Director · Officer: President and COO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)18,675——45,425Direct (D) No
F1
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
Open filing 0002045027-26-000002 Read from the filing’s XML Dispute this row
2026-02-03 Filed 2026-02-05Davis Hugh M. Director · Officer: President and COO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (18,675)
Disposed (D)18,6750—56,025Direct (D) No
F1, F2
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
  • F2 The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 3, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
Open filing 0002045027-26-000002 Read from the filing’s XML Dispute this row
2026-02-02 Filed 2026-02-06Loerop James Officer: Chief Business Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (97,700)
Acquired (A)97,7000—97,700Direct (D) No
F1, F2
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
  • F2 The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 2, 2026, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
Open filing 0001781549-26-000013 Read from the filing’s XML Dispute this row
2026-02-02 Filed 2026-02-06Loerop James Officer: Chief Business Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option (Right to Buy) — underlying Common Stock (341,900) — exercise price 3.61
Acquired (A)341,9000—341,900Direct (D) No
F3
  • F3 Exercisable with respect to 25% of the shares subject to the option vesting in four equal installments on the first, second, third and fourth anniversaries of February 2, 2026, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
Open filing 0001781549-26-000013 Read from the filing’s XML Dispute this row
2026-02-02 Filed 2026-02-06Balthaser Kevin Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (99,100)
Acquired (A)99,1000—99,100Direct (D) No
F1, F2
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
  • F2 The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 2, 2026, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
Open filing 0001957554-26-000009 Read from the filing’s XML Dispute this row
2026-02-02 Filed 2026-02-06Balthaser Kevin Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option (Right to Buy) — underlying Common Stock (346,800) — exercise price 3.61
Acquired (A)346,8000—346,800Direct (D) No
F3
  • F3 Exercisable with respect to 25% of the shares subject to the option vesting in four equal installments on the first, second, third and fourth anniversaries of February 2, 2026, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
Open filing 0001957554-26-000009 Read from the filing’s XML Dispute this row
2026-02-02 Filed 2026-02-06Hall Jesse Wayne Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (98,100)
Acquired (A)98,1000—98,100Direct (D) No
F1, F2
  • F1 Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
  • F2 The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 2, 2026, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
Open filing 0002065269-26-000002 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,905 filings read, the latest filed 2026-11-18. Prior quarter ending 2026-06-30: 9,170 filings read.

Showing 1–50 of 179

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
RA CAPITAL MANAGEMENT, L.P. 12,723,026 SH66,923,117 dollarsUnchanged Prior quarter: 12,723,026Open filing 0001104659-26-128411 Filed 2026-11-16 Dispute this row
BML Capital Management, LLC 10,955,000 SH57,623,300 dollarsLower by 1,020,000 Prior quarter: 11,975,000Open filing 0001754960-26-000981 Filed 2026-11-06 Dispute this row
BlackRock, Inc. Partly reported under another manager10,376,592 SH54,580,873 dollarsHigher by 339,584 Prior quarter: 10,037,008Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
Deep Track Capital, LP 9,345,000 SH49,154,700 dollarsUnchanged Prior quarter: 9,345,000Open filing 0001856083-26-000006 Filed 2026-11-16 Dispute this row
Frazier Life Sciences Management, L.P. 8,729,516 SH45,917,254 dollarsHigher by 3,804,142 Prior quarter: 4,925,374Open filing 0001892134-26-000007 Filed 2026-11-16 Dispute this row
FMR LLC Partly reported under another manager7,048,161 SH37,073,326 dollarsHigher by 6,734,311 Prior quarter: 313,850Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
Vivo Capital, LLC 6,694,637 SH35,213,791 dollarsUnchanged Prior quarter: 6,694,637Open filing 0001213900-26-119459 Filed 2026-11-13 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 5,864,619 SH30,847,896 dollarsHigher by 46,753 Prior quarter: 5,817,866Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
MPM BIOIMPACT LLC 5,178,127 SH27,236,948 dollarsHigher by 4,135,660 Prior quarter: 1,042,467Open filing 0001193125-26-463462 Filed 2026-11-16 Dispute this row
Decheng Capital LLC 4,041,736 SH21,259,531 dollarsUnchanged Prior quarter: 4,041,736Open filing 0001104659-26-127247 Filed 2026-11-13 Dispute this row
Rock Springs Capital Management LP 3,791,117 SH19,941,275 dollarsLower by 539,415 Prior quarter: 4,330,532Open filing 0001172661-26-005279 Filed 2026-11-16 Dispute this row
STATE STREET CORP Partly reported under another manager3,696,144 SH19,441,717 dollarsHigher by 440,804 Prior quarter: 3,255,340Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager3,585,794 SH18,865,362 dollarsHigher by 395,736 Prior quarter: 3,190,058Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
Jones Hill Capital LP 2,504,651 SH13,174,464 dollarsHigher by 745,159 Prior quarter: 1,759,492Open filing 0002102314-26-000006 Filed 2026-11-13 Dispute this row
STEMPOINT CAPITAL LP 2,050,698 SH10,786,671 dollarsNot in the prior quarter’s filings read Open filing 0001420506-26-002774 Filed 2026-11-16 Dispute this row
Siren, L.L.C. Partly reported under another manager2,025,000 SH10,651,500 dollarsNot in the prior quarter’s filings read Open filing 0002005245-26-000013 Filed 2026-11-12 Dispute this row
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,871,000 SH9,841,460 dollarsLower by 2,200,000 Prior quarter: 4,071,000Open filing 0001172661-26-005200 Filed 2026-11-16 Dispute this row
Kalehua Capital Management LLC 1,832,365 SH9,638,240 dollarsLower by 1,832,365 Prior quarter: 3,664,730Open filing 0002106181-26-000010 Filed 2026-11-13 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager1,775,495 SH9,339,104 dollarsHigher by 13,414 Prior quarter: 1,762,081Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
BRAIDWELL LP 1,753,978 SH9,225,924 dollarsLower by 388,370 Prior quarter: 2,142,348Open filing 0001420506-26-002894 Filed 2026-11-16 Dispute this row
Cormorant Asset Management, LP Partly reported under another manager1,750,000 SH9,205,000 dollarsNot in the prior quarter’s filings read Open filing 0001583977-26-000011 Filed 2026-11-16 Dispute this row
PANAGORA ASSET MANAGEMENT INC 1,479,505 SH7,782,196 dollarsHigher by 123,353 Prior quarter: 1,356,152Open filing 0000883677-26-000011 Filed 2026-11-12 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 1,421,966 SH7,479,541 dollarsLower by 43,769 Prior quarter: 1,465,735Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
Balyasny Asset Management L.P. 1,410,299 SH7,418,173 dollarsLower by 613,171 Prior quarter: 2,023,470Open filing 0001193125-26-463223 Filed 2026-11-16 Dispute this row
ACADIAN ASSET MANAGEMENT LLC Partly reported under another manager1,353,997 SH7,120 dollarsLower by 287,475 Prior quarter: 1,641,472Open filing 0001140361-26-042753 Filed 2026-11-09 Dispute this row
Woodline Partners LP 1,213,446 SH6,382,726 dollarsLower by 397,608 Prior quarter: 1,611,054Open filing 0001172661-26-005063 Filed 2026-11-16 Dispute this row
Squadron Capital Management LLC 1,200,000 SH6,312,000 dollarsNot in the prior quarter’s filings read Open filing 0002050709-26-000036 Filed 2026-11-16 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager1,193,916 SH6,279,998 dollarsHigher by 584,758 Prior quarter: 609,158Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1,187,780 SH6,247,723 dollarsHigher by 841,722 Prior quarter: 346,058Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
Palo Alto Investors LP 1,156,396 SH6,082,643 dollarsLower by 457,034 Prior quarter: 1,613,430Open filing 0002073679-26-000180 Filed 2026-11-16 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager1,003,635 SH5,279,120 dollarsHigher by 4,872 Prior quarter: 998,763Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
VANGUARD FIDUCIARY TRUST CO 941,759 SH4,953,652 dollarsHigher by 34,586 Prior quarter: 907,173Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
Aldebaran Capital, LLC 936,185 SH4,924,333 dollarsLower by 546 Prior quarter: 936,731Open filing 0001376474-26-000722 Filed 2026-11-13 Dispute this row
Connor, Clark Lunn Investment Management Ltd. 921,271 SH4,845,885 dollarsLower by 288,615 Prior quarter: 1,209,886Open filing 0001596800-26-000018 Filed 2026-11-10 Dispute this row
FRANKLIN TEMPLETON INC Partly reported under another manager871,027 SH3,205,379 dollarsNot in the prior quarter’s filings read Open filing 0000038777-26-000291 Filed 2026-11-12 Dispute this row
ExodusPoint Capital Management, LP 829,157 SH4,361,366 dollarsNot in the prior quarter’s filings read Open filing 0001736225-26-000013 Filed 2026-11-16 Dispute this row
Invesco Ltd. Partly reported under another manager812,563 SH4,274,081 dollarsHigher by 569,535 Prior quarter: 243,028Open filing 0000914208-26-000462 Filed 2026-11-12 Dispute this row
Three Bridge Wealth Advisors, LLC 714,823 SH3,759,969 dollarsUnchanged Prior quarter: 714,823Open filing 0001420506-26-002510 Filed 2026-11-05 Dispute this row
MARSHALL WACE, LLP Partly reported under another manager630,857 SH3,318,310 dollarsNot in the prior quarter’s filings read Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row
DIMENSIONAL FUND ADVISORS LP Partly reported under another manager513,840 SH2,703,077 dollarsUnchanged Prior quarter: 513,840Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row
CITADEL ADVISORS LLC Option: Call Partly reported under another manager487,100 SH2,562,146 dollarsLower by 33,900 Prior quarter: 521,000Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
UBS Group AG Partly reported under another manager484,501 SH2,548,476 dollarsHigher by 227,500 Prior quarter: 257,001Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager460,952 SH2,433,827 dollarsLower by 8,012 Prior quarter: 468,964Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
BARCLAYS PLC Partly reported under another manager447,830 SH2,355,585 dollarsHigher by 374,820 Prior quarter: 73,010Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row
Aisling Capital Management LP 434,455 SH2,285,233 dollarsUnchanged Prior quarter: 434,455Open filing 0001766721-26-000004 Filed 2026-11-12 Dispute this row
Bollard Group LLC 431,631 SH2,270 dollarsUnchanged Prior quarter: 431,631Open filing 0000929638-26-004282 Filed 2026-11-13 Dispute this row
WELLINGTON MANAGEMENT GROUP LLP Partly reported under another manager426,874 SH2,245,358 dollarsHigher by 159,376 Prior quarter: 267,498Open filing 0000902219-26-000323 Filed 2026-11-16 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Partly reported under another manager411,816 SH2,166,152 dollarsLower by 733 Prior quarter: 412,549Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
FRED ALGER MANAGEMENT, LLC 360,412 SH1,895,767 dollarsNot in the prior quarter’s filings read Open filing 0001193125-26-463608 Filed 2026-11-16 Dispute this row
Qube Research Technologies Ltd 326,939 SH1,719,699 dollarsNot in the prior quarter’s filings read Open filing 0001729829-26-000018 Filed 2026-11-13 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • ORBIMED ADVISORS LLC 421,500 SH
  • D. E. Shaw Co., Inc. 414,499 SH
  • Tetragon Partners GP Ltd 400,000 SH
  • Sixth Street Partners Management Company, L.P. 346,058 SH
  • SUPERSTRING CAPITAL MANAGEMENT LP 257,675 SH
  • Logos Global Management LP 200,000 SH
  • Atom Investors LP 148,855 SH
  • CenterBook Partners LP 118,228 SH
  • Verition Fund Management LLC 98,000 SH
  • MANGROVE PARTNERS IM, LLC 50,291 SH
  • SG Americas Securities, LLC 34,814 SH
  • State of Wyoming 27,439 SH
  • INTECH INVESTMENT MANAGEMENT LLC 24,668 SH
  • Walleye Capital LLC 19,576 SH
  • Empirical Financial Services, LLC d.b.a. Empirical Wealth Management 16,072 SH
  • Dynamic Technology Lab Private Ltd 13,521 SH
  • TWO SIGMA SECURITIES, LLC 12,671 SH
  • Jefferies Financial Group Inc. 11,000 SH
  • JANE STREET GROUP, LLC 10,300 SH
  • SIMPLEX TRADING, LLC 5,499 SH
  • Optiver Holding B.V. 336 SH
  • Integrated Wealth Concepts LLC 211 SH
  • Truvestments Capital LLC 150 SH
  • NATIONAL BANK OF CANADA /FI/ 102 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Biosion, Inc. Common Stock, $0.00001 par value4.77,521,30009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 2Open filing 0000929638-26-004367 Dispute this row
Bonita Biotech (HK) Ltd Common Stock, $0.00001 par value4.77,521,30009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 2Open filing 0000929638-26-004367 Dispute this row
Frazier Life Sciences Public Fund, L.P. Common Stock, $0.00001 par value5.47,879,943.0009/14/2026 Filed 2026-09-21SCHEDULE 13GOpen filing 0001231919-26-001199 Dispute this row
FHMLSP, L.P. Common Stock, $0.00001 par value5.47,879,943.0009/14/2026 Filed 2026-09-21SCHEDULE 13GOpen filing 0001231919-26-001199 Dispute this row
FHMLSP, L.L.C. Common Stock, $0.00001 par value5.47,879,943.0009/14/2026 Filed 2026-09-21SCHEDULE 13GOpen filing 0001231919-26-001199 Dispute this row
Frazier Life Sciences XI, L.P. Common Stock, $0.00001 par value0.186,910.0009/14/2026 Filed 2026-09-21SCHEDULE 13GOpen filing 0001231919-26-001199 Dispute this row
FHMLS XI, L.P. Common Stock, $0.00001 par value0.186,910.0009/14/2026 Filed 2026-09-21SCHEDULE 13GOpen filing 0001231919-26-001199 Dispute this row
FHMLS XI, L.L.C. Common Stock, $0.00001 par value0.186,910.0009/14/2026 Filed 2026-09-21SCHEDULE 13GOpen filing 0001231919-26-001199 Dispute this row
Frazier Life Sciences XII, L.P. Common Stock, $0.00001 par value0.5762,663.0009/14/2026 Filed 2026-09-21SCHEDULE 13GOpen filing 0001231919-26-001199 Dispute this row
FHMLS XII, L.P. Common Stock, $0.00001 par value0.5762,663.0009/14/2026 Filed 2026-09-21SCHEDULE 13GOpen filing 0001231919-26-001199 Dispute this row
FHMLS XII, L.L.C. Common Stock, $0.00001 par value0.5762,663.0009/14/2026 Filed 2026-09-21SCHEDULE 13GOpen filing 0001231919-26-001199 Dispute this row
RA Capital Management, L.P. Common Stock, $0.00001 par value per share9.112,723,026.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001231919-26-000915 Dispute this row
Peter Kolchinsky Common Stock, $0.00001 par value per share9.112,723,026.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001231919-26-000915 Dispute this row
Rajeev Shah Common Stock, $0.00001 par value per share9.112,723,026.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001231919-26-000915 Dispute this row
RA Capital Healthcare Fund, L.P. Common Stock, $0.00001 par value per share9.112,723,026.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001231919-26-000915 Dispute this row
BML Investment Partners, L.P. Common Stock, $0.00001 par value9.913,950,00004/23/2026 Filed 2026-04-27SCHEDULE 13G/AAmendment 5Open filing 0001373604-26-000033 Dispute this row
Vivo Opportunity Fund Holdings, L.P. Common Stock, $0.00001 par value4.35,966,370.0003/31/2026 Filed 2026-05-12SCHEDULE 13G/AAmendment 1Open filing 0001213900-26-055376 Dispute this row
Vivo Opportunity, LLC Common Stock, $0.00001 par value4.35,966,370.0003/31/2026 Filed 2026-05-12SCHEDULE 13G/AAmendment 1Open filing 0001213900-26-055376 Dispute this row
Vivo Opportunity Cayman Fund, L.P. Common Stock, $0.00001 par value0.5700,296.0003/31/2026 Filed 2026-05-12SCHEDULE 13G/AAmendment 1Open filing 0001213900-26-055376 Dispute this row
Vivo Opportunity Cayman, LLC Common Stock, $0.00001 par value0.5700,296.0003/31/2026 Filed 2026-05-12SCHEDULE 13G/AAmendment 1Open filing 0001213900-26-055376 Dispute this row
RA Capital Management, L.P. Common Stock, $0.00001 par value per share6.37,626,705.0003/31/2026 Filed 2026-04-07SCHEDULE 13GOpen filing 0001346824-26-000099 Dispute this row
Peter Kolchinsky Common Stock, $0.00001 par value per share6.37,626,705.0003/31/2026 Filed 2026-04-07SCHEDULE 13GOpen filing 0001346824-26-000099 Dispute this row
Rajeev Shah Common Stock, $0.00001 par value per share6.37,626,705.0003/31/2026 Filed 2026-04-07SCHEDULE 13GOpen filing 0001346824-26-000099 Dispute this row
RA Capital Healthcare Fund, L.P. Common Stock, $0.00001 par value per share6.37,626,705.0003/31/2026 Filed 2026-04-07SCHEDULE 13GOpen filing 0001346824-26-000099 Dispute this row
The Vanguard Group Common Stock0003/13/2026 Filed 2026-03-26SCHEDULE 13G/AAmendment 1Open filing 0000102909-26-000505 Dispute this row
Deep Track Capital, LP Common Stock, $0.00001 par value7.09,345,000.0003/09/2026 Filed 2026-03-17SCHEDULE 13GOpen filing 0001172661-26-001355 Dispute this row
Deep Track Biotechnology Master Fund, Ltd. Common Stock, $0.00001 par value7.09,345,000.0003/09/2026 Filed 2026-03-17SCHEDULE 13GOpen filing 0001172661-26-001355 Dispute this row
David Kroin Common Stock, $0.00001 par value7.09,345,000.0003/09/2026 Filed 2026-03-17SCHEDULE 13GOpen filing 0001172661-26-001355 Dispute this row
BML Investment Partners, L.P. Common Stock, $0.00001 par value11.914,250,00012/31/2025 Filed 2026-02-09SCHEDULE 13G/AAmendment 4Open filing 0001373604-26-000008 Dispute this row
BlackRock, Inc. Common Stock6.26,700,62912/31/2025 Filed 2026-01-21SCHEDULE 13G/AAmendment 1Open filing 0002012383-26-000630 Dispute this row
Biosion, Inc. Common Stock, $0.00001 par value9.411,281,95012/09/2025 Filed 2026-01-09SCHEDULE 13G/AAmendment 1Open filing 0000929638-26-000098 Dispute this row
Bonita Biotech (HK) Ltd Common Stock, $0.00001 par value9.411,281,95012/09/2025 Filed 2026-01-09SCHEDULE 13G/AAmendment 1Open filing 0000929638-26-000098 Dispute this row
Adage Capital Management, L.P. Common Stock, par value $0.00001 per share4.875,278,144.0009/30/2025 Filed 2025-11-13SCHEDULE 13G/AAmendment 2Open filing 0000902664-25-004888 Dispute this row
Robert Atchinson Common Stock, par value $0.00001 per share4.875,278,144.0009/30/2025 Filed 2025-11-13SCHEDULE 13G/AAmendment 2Open filing 0000902664-25-004888 Dispute this row
Phillip Gross Common Stock, par value $0.00001 per share4.875,278,144.0009/30/2025 Filed 2025-11-13SCHEDULE 13G/AAmendment 2Open filing 0000902664-25-004888 Dispute this row
The Vanguard Group Common Stock6.156,662,06306/30/2025 Filed 2025-07-29SCHEDULE 13GOpen filing 0000932471-25-000787 Dispute this row
Millennium Management LLC Common Stock, par value $0.00001 per share3.53,837,380.0006/30/2025 Filed 2025-07-24SCHEDULE 13G/AAmendment 1Open filing 0001104659-25-070388 Dispute this row
Millennium Group Management LLC Common Stock, par value $0.00001 per share3.53,837,380.0006/30/2025 Filed 2025-07-24SCHEDULE 13G/AAmendment 1Open filing 0001104659-25-070388 Dispute this row
Israel A. Englander Common Stock, par value $0.00001 per share3.53,837,380.0006/30/2025 Filed 2025-07-24SCHEDULE 13G/AAmendment 1Open filing 0001104659-25-070388 Dispute this row
BlackRock, Inc. Common Stock5.15,471,71106/30/2025 Filed 2025-07-17SCHEDULE 13GOpen filing 0002052113-25-002984 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,550,114 filings read, dated 2004-06-14 to 2026-11-18: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201517,857
2016222,642
2017222,009
2018223,345
2019216,482
2020176,407
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026262,403

Filings made before the SEC required XML are listed, not extracted.

Back to Aclaris Therapeutics, Inc.